Delivery Order SPE2DB20D3103-SPE2DB24FL3J1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of VYVANSE 30 MG CAPSULE 100S. The contract, valued at $5,441.66, is a firm fixed price delivery order with a period of performance through November 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,407.54 firm fixed-price delivery order covers the supply of VYVANSE 30 MG CAPSULE 100S, a medical commodity for the DLA. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,155.80 firm fixed-price delivery order is for the supply of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,120.14 firm-fixed-price delivery order is for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,235.28 firm fixed-price delivery order is for the supply of VYVANSE 70 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of November 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,813.10 Firm Fixed Price delivery order contract is for the supply of VYVANSE 30 MG CAPSULE 100S, a prescription medication. The award has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp is a $1,715.17 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA). The contract covers the procurement of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide VYVANSE 40 MG CAPSULE 100S. The $2,930.52 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to military...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,029.80 firm fixed-price delivery order contract is for the supply of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,743.40 firm fixed-price delivery order is for the supply of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FL3J1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,966.52 Firm Fixed Price Delivery Order contract is for the supply of VYVANSE 70 MG CAPSULE 100S. The award is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies across federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 10/10/23 |